CUNETMEDIX

Welcome to the Brand page for “CUNETMEDIX”, which is offered here for Pharmaceutical product, radiolabelled pharmaceutical preparations that target neuroendocrine tumor cell surface receptors for the detection and localization of neuroendocrine tumors in cancer patients and for targeted diagnostic management of the neuroendocrine tumors in cancer patients;.

Its status is currently believed to be active. Its class is unavailable. “CUNETMEDIX” is believed to be currently owned by “RadioMedix, Inc.”

Owner:
RADIOMEDIX, INC.
Owner Details
Description:
Pharmaceutical product, radiolabelled pharmaceutical preparations that target neuroendocrine tumor cell surface receptors for the detection and localization of neuroendocrine tumors in cancer patients and for targeted diagnostic management of the neuroendocrine tumors in cancer patients;
Categories: PHARMACEUTICAL PRODUCT